GeneDx Holdings Corp. (WGS) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $1.70B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $342.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $1.69B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $683.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $1.68B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $936.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $1.65B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.00M.
GeneDx Holdings Corp. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $3.00K | $1.70B | $342.00K | $-1.45B | $244.22M | 3 month · $6.34M 6 month · $15.34M | (m) |
| 2026-03-31 | $0.00 | $3.00K | $1.69B | $683.00K | $-1.44B | $254.12M | 3 month · $9.00M | (m) |
| 2025-12-31 | $0.00 | $3.00K | $1.68B | $936.00K | $-1.37B | $308.18M | 12 month · $32.16M | (m) |
| 2025-09-30 | $0.00 | $2.00K | $1.65B | $1.00M | $-1.36B | $292.26M | 3 month · $10.59M 9 month · $22.38M | (m) |
| 2025-06-30 | $0.00 | $2.00K | $1.62B | $812.00K | $-1.35B | $277.13M | 3 month · $7.81M 6 month · $11.80M | (m) |
| 2025-03-31 | $0.00 | $2.00K | $1.62B | $905.00K | $-1.36B | $257.40M | 3 month · $3.98M | (m) |
| 2024-12-31 | $0.00 | $2.00K | $1.60B | $830.00K | $-1.35B | $245.25M | 12 month · $9.14M | (m) |
| 2024-09-30 | $0.00 | $2.00K | $1.56B | $918.00K | $-1.36B | $204.50M | 3 month · $3.64M 9 month · $6.29M | (m) |
| 2024-06-30 | $0.00 | $2.00K | $1.54B | $459.00K | $-1.35B | $194.04M | 3 month · $3.11M 6 month · $2.66M | (m) |
| 2024-03-31 | $0.00 | $2.00K | $1.53B | $291.00K | $-1.32B | $207.22M | 3 month · $-451.00K | (m) |
| 2023-12-31 | $0.00 | $2.00K | $1.53B | $425.00K | $-1.30B | $228.02M | 12 month · $-326.00K | (m) |
| 2023-09-30 | $0.00 | $2.00K | $1.53B | (m) | $-1.27B | $254.26M | 3 month · $431.00K 9 month · $586.00K | (m) |
| 2023-06-30 | $0.00 | $2.00K | $1.53B | (m) | $-1.23B | $296.11M | 3 month · $107.00K 6 month · $156.00K | (m) |
| 2023-03-31 | $0.00 | $2.00K | $1.51B | (m) | $-1.19B | $328.47M | 3 month · $48.00K | (m) |
| 2022-12-31 | $0.00 | $1.00K | $1.38B | $0.00 | $-1.12B | $253.71M | 12 month · $41.98M | (m) |
| 2022-09-30 | $0.00 | $38.00K | $1.38B | (m) | $-815.66M | $561.29M | 3 month · $1.27M 9 month · $41.55M | 9 month · $197.66M |
| 2022-06-30 | $0.00 | $38.00K | $1.38B | (m) | $-738.08M | $637.27M | 3 month · $22.72M 6 month · $40.28M | 3 month · $197.66M 6 month · $197.66M |
| 2022-03-31 | $0.00 | $24.00K | $981.76M | (m) | $-652.34M | $329.44M | 3 month · $17.56M | (m) |
| 2021-12-31 | $0.00 | $24.00K | $963.52M | (m) | $-575.44M | $388.10M | 12 month · $42.38M | (m) |
| 2021-09-30 | $0.00 | (m) | $926.25M | (m) | $-535.26M | $391.02M | 3 month · $5.42M 9 month · $5.42M | (m) |
| 2021-06-30 | $0.00 | $1.35K | $1.48M | (m) | $-567.99M | $-566.50M | (m) | (m) |
| 2021-03-31 | $0.00 | $1.48K | $0.00 | (m) | $-521.83M | $-521.83M | (m) | (m) |
| 2020-12-31 | $0.00 | $895.00 | $0.00 | (m) | $-330.05M | $-330.05M | (m) | (m) |
| 2020-09-30 | (m) | $191.00 | $5.06M | (m) | $-56.92K | $-204.37M | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-147.75M | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-88.71M | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $-55.97M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |